Certolizumab Pegol for Treatment of Adult Greek Patients With Moderate to Severe Crohn's Disease Who Failed Infliximab

Clinical trial NCT00307931 · TERMINATED

Trial details

NCT number: NCT00307931
Sponsor: UCB Pharma
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Crohn's Disease

Start date: 2007-04-01
Primary completion: 2008-08-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.